Salyka Sengsayadeth

The use of venetoclax‐based salvage therapy for post‐hematopoietic cell transplantation relapse of acute myeloid leukemia

Michael Byrne, Nathalie Danielson, Salyka Sengsayadeth et al. · American Journal of Hematology · 2020 · 78 citations · Full text

Cell Therapy, Mixed-phenotype Acute Leukemia, Immunology +20

Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count

Vanessa E. Kennedy, Heidi Chen, Bipin N. Savani et al. · Biology of Blood and Marrow Transplantation · 2017 · 69 citations · Full text

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers

Salyka Sengsayadeth, Madan Jagasia, Barbara Engelhardt et al. · Bone Marrow Transplantation · 2012 · 66 citations

Conventional Markers, Oncogenic Agent, Medicine +10

Does FLT3 mutation impact survival after hematopoietic stem cell transplantation for acute myeloid leukemia? A Center for International Blood and Marrow Transplant Research (CIBMTR) analysis

Abhinav Deol, Salyka Sengsayadeth, Kwang Woo Ahn et al. · Cancer · 2016 · 58 citations · Full text

Transplant Outcomes for Secondary Acute Myeloid Leukemia: Acute Leukemia Working Party of the European Society for Blood and Bone Marrow Transplantation Study

Salyka Sengsayadeth, Myriam Labopin, Ariane Boumendil et al. · Biology of Blood and Marrow Transplantation · 2018 · 58 citations · Full text